相关实验视频
Updated: Jun 16, 2025
04:39
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
Published on: March 17, 2023
1.6K
虫衍生物图夫辛-合醇用于治疗自身免疫性疾病
Miri Blank1, Yehuda Shoenfeld1
1Zabludowicz center for autoimmune diseases, Sheba Medical Center, Ramat Gan. Israel; Reichman University, Herzelia, Israel.
Autoimmunity reviews
|August 19, 2024
概括
一种新型的小分子,图夫辛-醇胆 (TPC),模仿虫分泌物调节免疫反应. 作为一种针对自身免疫性疾病的新疗法,TPC显得有前途,其副作用比目前的治疗方法少.
科学领域:
- 免疫学 免疫学 免疫学
- 药物发现 药物发现 药物发现
- 分子医学是分子医学.
背景情况:
- 自身免疫性疾病影响5-10%的人口,导致严重的发病率和医疗费用.
- 目前的治疗方法抑制免疫系统,增加感染易感性.
- 对于具有最小副作用的新型免疫调节疗法有着极大的需求.
研究的目的:
- 为了研究一种新型小分子的免疫调节活性,图夫辛-酸化胆 (TPC).
- 阐明TPC在自身免疫性疾病模型中的作用机制.
- 评估TPC对自身免疫性疾病的治疗潜力.
主要方法:
- 构建一个双功能小分子,TPC,模仿虫分泌化合物.
- 在四种自身免疫疾病的小鼠模型中对TPC的评估.
- 对TPC对人体外围血液单核细胞 (PBMC) 和巨细胞动脉炎患者活检的影响的实体分析.
主要成果:
- 在小鼠自身免疫模型中,TPC表现出显著的免疫调节活性.
- 该分子减弱了临床评分,并减少了炎症反应.
- TPC调节了宿主免疫系统,在人类细胞和组织样本中显示出有效性.
结论:
- TPC表现出强大的免疫调节作用,表明其作为一种新型治疗剂的潜力.
- 该研究提供了TPC的作用机制的见解.
- TPC是开发更安全,更有效的自身免疫疾病治疗方法的有希望的候选人.
相关概念视频
01:29Autoimmune Disorders
398
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
398
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
145
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
145
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
120
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
120
01:27Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
01:24T Cell Types and Functions
964
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
964